Research - June 2021 Archives

ROCHESTER, Minn. — Mayo Clinic researchers are taking a close look at rare cases of inflammation of the heart muscle, or myocarditis, in young men ...

ROCHESTER, Minn. — Performing the first cardiac scan on their new photon-counting-detector CT scanner was a once-in-a-career moment for Joel (J.G.) Fletcher, M.D., and Cynthia ...

One of the most common prescription drugs in America – levothyroxine – is used by people with underactive thyroid glands, also known as hypothyroidism. However, ...

Mayo Clinic researchers and collaborators used computer simulation and artificial intelligence to virtually screen 30 million drug candidates that may block SARS-CoV-2, the virus that ...

A team from the University of Illinois Urbana-Champaign’s Grainger College of Engineering and Mayo Clinic have developed a new technique for creating “microcancer” cell cultures. ...

ROCHESTER, Minn. — Researchers at Mayo Clinic Cancer Center are studying a potential new chimeric antigen receptor-T cell therapy (CAR-T cell therapy) treatment for multiple myeloma. ...

At the beginning of 2020, everyone in research and medicine who could pivot to focus on COVID-19 did. Scientists and physicians hauled out findings from ...

Mikaili Robertson has a passion for playing college sports, so the second baseman was devastated when at age 18 he learned he needed a hip ...

Mayo Clinic Laboratories has launched a first-of-its-kind test to detect an autoimmune disease called testicular cancer-associated paraneoplastic encephalitis. The test, available nationally and internationally, detects the Kelch-like ...

Last week, the Food and Drug Administration approved aducanumab to treat Alzheimer’s disease, which is a progressive brain disorder that is the most common cause ...

ROCHESTER, Minn. — Artificial intelligence (AI) may offer a way to accurately determine that a person is not infected with COVID-19. An international retrospective study ...

PHOENIX — Mayo Clinic researchers are studying a new class of immunotherapy drugs called "bispecific antibodies" that have demonstrated potent tumor-killing activity in multiple myeloma. A ...